BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16575743)

  • 1. Vancomycin-resistant enterococcal bloodstream infection-related mortality: focus on the lack of appropriate therapy.
    Nannini EC
    Clin Infect Dis; 2006 Apr; 42(8):1203-4; author reply 1204-5. PubMed ID: 16575743
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality due to vancomycin-resistant enterococcal bacteremia versus vancomycin-susceptible enterococcal bacteremia: an ecological analysis.
    Hurley JC
    Clin Infect Dis; 2005 Nov; 41(10):1541-2. PubMed ID: 16231272
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
    DiazGranados CA; Jernigan JA
    J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant enterococcal bacteremia.
    Boyce JM
    Clin Infect Dis; 2002 Dec; 35(11):1445-6; discsussion 1446. PubMed ID: 12439814
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.
    Lodise TP; McKinnon PS; Tam VH; Rybak MJ
    Clin Infect Dis; 2002 Apr; 34(7):922-9. PubMed ID: 11880957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia?
    Krcmery V; Bilíková E; Svetlansky I; Kovacicová G
    Clin Infect Dis; 2001 Apr; 32(7):1110-2. PubMed ID: 11264043
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.
    Garbutt JM; Ventrapragada M; Littenberg B; Mundy LM
    Clin Infect Dis; 2000 Mar; 30(3):466-72. PubMed ID: 10722429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 17-year study of bloodstream infection after liver transplantation: resistance rate, risk factor and mortality of enterococcal bloodstream infections].
    Tai Q; He XS; Hu AB; Wu LW; Ju WQ; Zhu XF; Ma Y; Wang DP; Wang GD; Guo ZY; Huang JF
    Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(46):3279-82. PubMed ID: 21223787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First recurrent infection with vancomycin-resistant enterococcus from Turkey.
    Citak EC; Oguz A; Karadeniz C; Okur V; Basustaoglu A; Arman D
    J Infect; 2006 Sep; 53(3):e147-50. PubMed ID: 16413059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.
    Vergis EN; Hayden MK; Chow JW; Snydman DR; Zervos MJ; Linden PK; Wagener MM; Schmitt B; Muder RR
    Ann Intern Med; 2001 Oct; 135(7):484-92. PubMed ID: 11578151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.
    DiazGranados CA; Zimmer SM; Klein M; Jernigan JA
    Clin Infect Dis; 2005 Aug; 41(3):327-33. PubMed ID: 16007529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
    J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of vancomycin resistance and death in enterococcal bacteremia.
    Ann Intern Med; 2001 Oct; 135(7):S-43. PubMed ID: 11596573
    [No Abstract]   [Full Text] [Related]  

  • 15. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.
    Matar MJ; Tarrand J; Raad I; Rolston KV
    Am J Infect Control; 2006 Oct; 34(8):534-6. PubMed ID: 17015161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
    Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
    BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia.
    Caballero-Granado FJ; Becerril B; Cuberos L; Bernabeu M; Cisneros JM; Pachón J
    Clin Infect Dis; 2001 Feb; 32(4):587-94. PubMed ID: 11181122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to Nannini and to a previous letter by Hurley.
    DiazGranados CA; Jernigan JA
    Clin Infect Dis; 2006 Apr; 42(8):1204-5. PubMed ID: 16575744
    [No Abstract]   [Full Text] [Related]  

  • 19. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
    Cunha BA; Mickail N; Eisenstein L
    Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should clinicians worry about vancomycin-resistant Enterococcus bloodstream infections?
    Salgado CD; Ison MG
    Bone Marrow Transplant; 2006 Dec; 38(12):771-4. PubMed ID: 17133239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.